 Desmopressin antifibrinolytics Desmopressin safe effective hemostatic agent use surgery patients mild hemophilia von Willebrand disease Uremic patients substitution desmopressin cryoprecipitate bleeding variable response individual patients hemophilia von Willebrand disease patient trial administration surgery surgery verification effective increase Factor VIII vWF desmopressin Use desmopressin patients normal baseline hemostatic function advantageous certain patient subgroups prospective studies drug safety cases Data role desmopressin surgery patients aspirin Antifibrinolytic therapy risk cardiac surgery addition specific use urological surgery beneficial absence upper urinary tract last ten years applications antifibrinolytic therapy surgical intracranial aneurysms oral lacrimal surgery nonsurgical cancer patients gastrointestinal bleeding anecdotal reports fears increased thrombosis antifibrinolytics studies risk